Literature DB >> 27636237

A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.

Emily Huesgen1, Kathryn E DeSear1, Eric F Egelund1, Renata Smith2, Blake Max2,3, Jennifer Janelle4.   

Abstract

Selection of an appropriate antiretroviral regimen for the patient infected with human immunodeficiency virus can be challenging, as various considerations must be taken into account including viral resistance mutations, patient comorbidities, drug interactions, and the potential for drug-related adverse effects and toxicities. Treatment is further complicated when a clinical scenario arises requiring an alteration in the dosage form. Factors ranging from dysphagia to administration through an enteral feeding tube can affect decisions regarding antiretroviral dosage forms. Limited pharmacokinetic data exist regarding the alteration of antiretroviral medications from their original form. Bioavailability may vary substantially between dosage forms, which can lead to unpredictable drug concentrations. Supratherapeutic or subtherapeutic antiretroviral drug concentrations can result in increased toxicity, virologic failure, or the emergence of drug resistance. We performed a systematic literature search to review the available antiretroviral literature on the modification of solid dosage forms as well as alternative routes of administration of oral antiretroviral agents and their application to clinical practice.
© 2016 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  alternative administration; antiretroviral formulations; bioequivalence; crush; enteral tube; pharmacokinetics; split

Mesh:

Substances:

Year:  2016        PMID: 27636237     DOI: 10.1002/phar.1835

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

1.  Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.

Authors:  Honami Sato; Takahiro Kobayashi; Nanako Fujita; Takaya Yamashita; Akihiro Kitadate; Tomoko Yoshioka; Miho Nara; Yoshihiro Kameoka; Masatomo Miura; Naoto Takahashi
Journal:  Cancer Chemother Pharmacol       Date:  2022-08-13       Impact factor: 3.288

Review 2.  The management of treatment-experienced HIV patients (including virologic failure and switches).

Authors:  James Cutrell; Tomasz Jodlowski; Roger Bedimo
Journal:  Ther Adv Infect Dis       Date:  2020-01-20

3.  Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients.

Authors:  D Zanon; U M Musazzi; A Manca; A De Nicolò; A D'Avolio; F Cilurzo; N Maximova; C Tomasello; E Clementi; P Minghetti
Journal:  Data Brief       Date:  2020-10-23

4.  Long-Term Administration of Abacavir and Etravirine Impairs Semen Quality and Alters Redox System and Bone Metabolism in Growing Male Wistar Rats.

Authors:  Agnieszka Matuszewska; Beata Nowak; Wojciech Niżański; Maria Eberhardt; Kinga Domrazek; Anna Nikodem; Benita Wiatrak; Krzysztof Zduniak; Kamil Olejnik; Anna Merwid-Ląd; Tomasz Tomkalski; Diana Jędrzejuk; Ewa Szeląg; Marzenna Podhorska-Okołów; Aleksandra Piotrowska; Izabela Jęśkowiak; Agata Heinrich; Maria Rutkowska; Wojciech Dziewiszek; Tomasz Sozański; Joanna Kwiatkowska; Paulina Jawień; Marek Bolanowski; Adam Szeląg
Journal:  Oxid Med Cell Longev       Date:  2021-07-29       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.